Seattle Genetics, Genentech expand deal

Seattle Genetics Inc. (NASDAQ:SGEN) added antigens to a 2002 deal that gave

Read the full 123 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE